These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 19659984

  • 1. Refractory subacute cutaneous lupus erythematosus successfully treated with rituximab.
    Kieu V, O'Brien T, Yap LM, Baker C, Foley P, Mason G, Prince HM, McCormack C.
    Australas J Dermatol; 2009 Aug; 50(3):202-6. PubMed ID: 19659984
    [Abstract] [Full Text] [Related]

  • 2. Cutaneous lupus erythematosus: issues in diagnosis and treatment.
    Walling HW, Sontheimer RD.
    Am J Clin Dermatol; 2009 Aug; 10(6):365-81. PubMed ID: 19824738
    [Abstract] [Full Text] [Related]

  • 3. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
    Camous L, Melander C, Vallet M, Squalli T, Knebelmann B, Noël LH, Fakhouri F.
    Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
    Faurschou A, Gniadecki R.
    Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases.
    El-Hallak M, Binstadt BA, Leichtner AM, Bennett CM, Neufeld EJ, Fuhlbrigge RC, Zurakowski D, Sundel RP.
    J Pediatr; 2007 Apr; 150(4):376-82. PubMed ID: 17382113
    [Abstract] [Full Text] [Related]

  • 8. Calcifying lupus panniculitis in a patient with subacute cutaneous lupus erythematosus: response to diltiazem and chloroquine.
    Morgan KW, Callen JP.
    J Rheumatol; 2001 Sep; 28(9):2129-32. PubMed ID: 11550987
    [Abstract] [Full Text] [Related]

  • 9. [Efficacy of rituximab in a case of refractory bullous pemphigoid].
    Reguiaï Z, Tchen T, Perceau G, Bernard P.
    Ann Dermatol Venereol; 2009 May; 136(5):431-4. PubMed ID: 19442800
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
    Günther C, Meurer M, Stein A, Viehweg A, Lee-Kirsch MA.
    Dermatology; 2009 May; 219(2):162-6. PubMed ID: 19478477
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 14. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D.
    Br J Dermatol; 2008 Feb; 158(2):382-8. PubMed ID: 18070210
    [Abstract] [Full Text] [Related]

  • 15. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus.
    Ruzicka T, Meurer M, Bieber T.
    Arch Dermatol; 1988 Jun; 124(6):897-902. PubMed ID: 2967674
    [Abstract] [Full Text] [Related]

  • 16. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [Abstract] [Full Text] [Related]

  • 17. Subacute cutaneous lupus erythematosus presenting as erythroderma.
    Kalavala M, Shah V, Blackford S.
    Clin Exp Dermatol; 2007 Jul; 32(4):388-90. PubMed ID: 17459074
    [Abstract] [Full Text] [Related]

  • 18. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
    Cortés-Hernández J, Torres-Salido M, Castro-Marrero J, Vilardell-Tarres M, Ordi-Ros J.
    Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
    [Abstract] [Full Text] [Related]

  • 19. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T.
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [Abstract] [Full Text] [Related]

  • 20. Disease activity-guided rituximab therapy in rheumatoid arthritis: the effects of re-treatment in initial nonresponders versus initial responders.
    Thurlings RM, Vos K, Gerlag DM, Tak PP.
    Arthritis Rheum; 2008 Dec; 58(12):3657-64. PubMed ID: 19035505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.